Poll Shows a Lot of Americans are Unwilling to Buy CBD Sans FDA Regulations

October 29, 2019 15:00:29

Last December, Congress passed the Farm Bill, a legislation that legalized the cultivation of industrial hemp. This came after spirited efforts by lobbyists and a group of senators led by Senate Majority Leader Mitch McConnell to legalize hemp, the plant which produces cannabidiol (CBD). Their efforts were backed by the knowledge of a market ready and willing to purchase CBD products.

However, a recent poll has revealed some troubling news. The fact that the FDA hasn’t come up with regulations is hurting the industry. And worse, people who need the benefits that CBD offers are avoiding it due to the uncertainty of…

Read More >>

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com